CC
STJ

Coastland Capital’s St Jude Medical STJ Stock Holding History

Coastland Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-355,443
Closed -$28.5M – 139
2016
Q4 		$28.5M Buy
+355,443
New +$28.2M 0.79% 38
2016
Q3 		– Sell
-491,803
Closed -$39.7M – 115
2016
Q2 		$38.5M Buy
+491,803
New +$35.1M 1.57% 14

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Coastland Capital's STJ Position: Q1 2017 in Review

Coastland Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 355,443 shares — an estimated $28.5M sold.

Coastland Capital first reported a position in STJ in Q2 2016 and held it in 2 quarters. The position peaked at $38.5M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Coastland Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Coastland Capital sold 355,443 St Jude Medical shares in Q1 2017, an estimated $28.5M.
  • Coastland Capital first reported a position in St Jude Medical in Q2 2016 and held it in 2 quarters.
  • Coastland Capital's St Jude Medical position peaked at $38.5M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Coastland Capital's 13F filing for Q1 2017, filed 15 May 2017.